跳至主要内容
临床试验/NCT05179304
NCT05179304Unknown不适用

Aesthetic Outcomes of Oncoplastic Breast Surgery With a Droplet-Shaped Glandular Flap for Breast Cancer in the Upper Inner Quadrant

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2022年1月18日最近更新:
适应症

试验速览

阶段
不适用
入组人数
109
试验地点
1
主要终点
aesthetic outcomes

研究概览

简要总结

Oncoplastic breast surgery, combining oncological resection with plastic surgical techniques, has emerged as an important surgical strategy to optimize conventional breast-conserving surgery. The upper inner quadrant is one of the most difficult and challenging tumor locations for surgeons to perform oncoplastic breast surgery. There is a pressing need to develop a simple and effective oncoplastic surgical technique to cope with the unfavorable anatomy and location of tumors in the UIQ. Here, we present a new oncoplastic volume displacement technique for UIQ using the DSG flap. This trial was design to estimate the aesthetic outcomes of an oncoplastic technique using a droplet-shaped glandular flap for breast cancer in the upper inner quadrant.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Signed the informed consent.
  • Female aged between 18 and 70 years.
  • Pathologically diagnosed operable breast cancer.
  • WHO Eastern Cooperative Oncology Group (ECOG) performance status of 0-
  • Cancer located in the upper inner quadrant; Single tumor or multiple tumors in the same quadrant.
  • The important organ functions meet the following criteria:
  • WBC >=3.0 x 10^9/L; Neutrophilic granulocytes >=1.5×10^9/L; Platelet >=100 x 10^9/L; Hb >=9 g/dL;
  • Total bilirubin no more than 1.5 times the normal upper limit (ULN); AST and ALT no more than 1.5 times ULN; AKP no more than 2.5 times ULN;
  • Serum creatinine no more than 1.5 times ULN or Clearance rate of creatinine >= 60ml/min;
  • Thyroid stimulating hormone (TSH) <= ULN (T3, T4 levels need to be detected simultaneously if abnormalities, the patient can be included if T3, T4 levels is normal);
  • LVEF basement >= 50%.
  • Adjust to the criteria of breast conserving surgery.

排除标准

  • Multifocal or multicentric disease.
  • Tumor localized in the central quadrant or the distance to the nipple < 2 cm;
  • Diffused calcifications with fine plemorphic or fine linear or fine-linear branching morphology.
  • The ratio of tumor to breast > 20%;
  • The diameter of tumor is up to 4 cm;
  • Women in the early or intermediate stage of pregnancy;
  • Prior history of breast radiation;
  • Any severe comorbidities, inability to give informed consent or unavailability for follow-up.

结局指标

主要结局

aesthetic outcomes

时间窗: half a year to one year

ABNSW system. The total score was 15 points, outcomes were good when it was 11-14, fair when it was 6-10, and poor when it was 0-5.

次要结局

  • Local recurrence(half a year to one year)
  • Patients complications after surgery(half a year to one year)
  • Patients' quality of life(half a year to one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shicheng Su

Director of Shuhua Breast Cancer Research Center of Sun Yat-Sen Memorial Hospital

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

研究点 (1)

Loading locations...

相似试验